Prokidney to present at the j.p. morgan 41st annual healthcare conference

Winston-salem, n.c., dec. 22, 2022 (globe newswire) -- prokidney corp. (nasdaq: prok) (“prokidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (ckd), today announced that dr. tim bertram, chief executive officer, will present at the j.p. morgan 41st annual healthcare conference in san francisco on wednesday, january 11th, 2023, at 3:45 pm pt.
PROK Ratings Summary
PROK Quant Ranking